WO2022156876A1 - Formulations de protéines - Google Patents
Formulations de protéines Download PDFInfo
- Publication number
- WO2022156876A1 WO2022156876A1 PCT/EP2021/050998 EP2021050998W WO2022156876A1 WO 2022156876 A1 WO2022156876 A1 WO 2022156876A1 EP 2021050998 W EP2021050998 W EP 2021050998W WO 2022156876 A1 WO2022156876 A1 WO 2022156876A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- composition
- proteins
- use according
- total
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 142
- 102000004169 proteins and genes Human genes 0.000 title claims description 78
- 108090000623 proteins and genes Proteins 0.000 title claims description 78
- 238000009472 formulation Methods 0.000 title description 13
- 239000002537 cosmetic Substances 0.000 claims abstract description 17
- 235000018102 proteins Nutrition 0.000 claims description 77
- 235000014121 butter Nutrition 0.000 claims description 22
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 18
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 14
- 239000003974 emollient agent Substances 0.000 claims description 13
- 102000006395 Globulins Human genes 0.000 claims description 9
- 108010044091 Globulins Proteins 0.000 claims description 9
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 claims description 8
- 244000020551 Helianthus annuus Species 0.000 claims description 8
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- 108010084695 Pea Proteins Proteins 0.000 claims description 8
- 235000010749 Vicia faba Nutrition 0.000 claims description 8
- 240000006677 Vicia faba Species 0.000 claims description 8
- 235000002098 Vicia faba var. major Nutrition 0.000 claims description 8
- 235000019705 chickpea protein Nutrition 0.000 claims description 8
- 235000019704 lentil protein Nutrition 0.000 claims description 8
- 235000019702 pea protein Nutrition 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- 108010088751 Albumins Proteins 0.000 claims description 7
- 102000009027 Albumins Human genes 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- 241000195493 Cryptophyta Species 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 102000011782 Keratins Human genes 0.000 claims description 5
- 108010076876 Keratins Proteins 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 102000034238 globular proteins Human genes 0.000 claims description 5
- 108091005896 globular proteins Proteins 0.000 claims description 5
- 241000454552 Astrocaryum murumuru Species 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 claims description 2
- 239000001341 hydroxy propyl starch Substances 0.000 claims description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 5
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 3
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 3
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 3
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 3
- 239000004904 UV filter Substances 0.000 description 3
- 229960005193 avobenzone Drugs 0.000 description 3
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 3
- 239000008406 cosmetic ingredient Substances 0.000 description 3
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 3
- 229960000601 octocrylene Drugs 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- CENPSTJGQOQKKW-UHFFFAOYSA-N 2,4,6-tris(4-phenylphenyl)-1,3,5-triazine Chemical compound C1=CC=CC=C1C1=CC=C(C=2N=C(N=C(N=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=C1 CENPSTJGQOQKKW-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940040102 levulinic acid Drugs 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 229940058349 sodium levulinate Drugs 0.000 description 2
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000010496 thistle oil Substances 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- HVGWFBLSVZHTTQ-JYPJBZIJSA-N (5r,6s,7r,8r)-1,2,5,6,7,8,9-heptahydroxynonan-4-one Chemical compound OCC(O)CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO HVGWFBLSVZHTTQ-JYPJBZIJSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-JLHYYAGUSA-N 4-[(e)-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C\C1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-JLHYYAGUSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 101710091838 Convicilin Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 101710196023 Vicilin Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MIJPAVRNWPDMOR-UHFFFAOYSA-N [2-(1,2-dihydroxyethyl)-3-hydroxy-5-oxo-2h-furan-4-yl] dihydrogen phosphate Chemical compound OCC(O)C1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229940084760 glycyrrhiza inflata root extract Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- WIDNAJNXDPHROL-UHFFFAOYSA-N n-[4-(2,4-dihydroxyphenyl)-1,3-thiazol-2-yl]-2-methylpropanamide Chemical compound S1C(NC(=O)C(C)C)=NC(C=2C(=CC(O)=CC=2)O)=C1 WIDNAJNXDPHROL-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention belongs to the cosmetic field and relates to a cosmetic composition comprising proteins.
- a beautiful and attractive appearance is a desire for many people.
- One typical sign of such an appearance is a healthy and smooth looking skin. Therefore, in order to take care on the skin, it is for many people a daily routine to apply cosmetic products such as body lotions, sunscreens or deodorant compositions.
- Body lotions Cosmetic skin care compositions which are meant to be applied to the whole body apart from the head are commonly called body lotions.
- Those products are usually characterized in that they comprise an aqueous phase and an oil phase, whereby one of the two phases is suspended in the other.
- those formulations are stabilized by emulsifiers avoiding a separation of the two phase. Due to the suspension of both phases the formulations usually have a milk like appearance.
- Formulations which are particular suitable to be used as body lotion are commonly characterized in that they have a viscosity in the range from 1000 to 15000 mPa s at 25°C.
- the present invention is a cosmetic skin care composition
- a cosmetic skin care composition comprising, based on the total weight of the composition, a) 0.05 to 8.0% by weight of at least one protein, b) at least one emollient, and c) Water.
- normal conditions refers to 20°C, 1013 hPa and a relative humidity of 50%.
- skin refers solely to human skin.
- a further object of the present invention is the use, based on the total weight of the composition, of 0.05% to 8.0% by weight of at least one protein and at least one emollient to thicken a cosmetic skin care composition further containing water.
- composition according to the invention is characterized in that it is an oil in water emulsion.
- the total content of the proteins in the compositions is from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- Fibrous proteins are linear (long fibrous) in shape. Typical examples are a-Keratin, - Keratin and Collagen. Globular proteins are spherical or globular in shape. Typical examples are those found in the group of globulins. Particular examples are a-lactalbumin, p- lactoglobulin, myoglobin and hemoglobin.
- proteins may also be classified according to their composition:
- Simple proteins are composed of only amino acids, whereby the proteins may be fibrous or globular. Typical simple proteins are bovine albumin and casein.
- Conjugate proteins are complex proteins, which contain one or more non-amino acid components. Typical examples are lipoproteins or glycoproteins.
- the at least one protein contained is characterized in that the protein contained is a globular protein.
- the total content of the globular protein(s) in the composition is from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- the composition comprises at least one protein selected from the group of proteins that are globulin and/or albumin.
- Globulins and albumins are globular proteins. Globulins are proteins which, for example are present in peas.
- the total quantity of those proteins is in the range from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- the total content of the globulins in the composition is from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- the total content of the albumins in the composition is from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- the composition comprises one or more proteins of the group consisting of plant based proteins. Plant based proteins are considered as proteins which are soured from plants in any form.
- the total quantity of plant based proteins is in the range from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- the composition comprises one or more proteins of the group consisting of sunflower proteins, chickpea proteins, pea proteins, lentil proteins, lupin proteins, rice protein, fava bean protein, collagen, keratin, algae derived proteins and yeast derived proteins.
- sunflower proteins More preferred are sunflower proteins, chickpea proteins, pea proteins, lentil proteins, lupin proteins, rice protein, fava bean protein, algae derived proteins and/or yeast derived proteins.
- sunflower proteins Most preferred are sunflower proteins, chickpea proteins, pea proteins, lentil proteins, lupin proteins, rice protein and/or fava bean protein.
- the total quantity of the proteins selected from the group consisting of sunflower proteins, chickpea proteins, pea proteins, lentil proteins, lupin proteins, rice protein, fava bean protein, collagen, keratin, algae derived proteins and yeast derived proteins is in the range from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- the total quantity of the proteins selected from the group consisting of sunflower proteins, chickpea proteins, pea proteins, lentil proteins, lupin proteins, rice protein, fava bean protein, algae derived proteins and yeast derived proteins is in the range from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- the total quantity of the proteins selected from the group consisting of sunflower proteins, chickpea proteins, pea proteins, lentil proteins, lupin proteins, rice protein and fava bean protein is in the range from 0.05% to 8.0%, more preferably from 2.1% to 6.0% by weight and most preferably from 2.8% to 4.8% by weight, calculated to the total weight of the composition.
- composition is characterized in that it comprises at least one emollient.
- Emollients are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "emollient”.
- the total quantity of the emollients is in the range from 0.5 to 20% by weight, more preferably 5% to 18% by weight and most preferred 8% to 15% by weight, calculated to the total weight of the composition.
- Preferred emollients to be contained in the composition are selected from the group of cosmetic butters. It is particular preferred if cupuacu butter, murumuru butter and/or butyrospermum parkii (shea) butter are contained. It is most preferred if the emollient system comprises at least butyrospermum parkii (shea) butter.
- the total quantity of the cosmetic butters is in the range from 0.5 to 20% by weight, more preferably 5% to 18% by weight and most preferred 8% to 15% by weight, calculated to the total weight of the composition.
- cupuacu butter, murumuru butter and/or butyrospermum parkii (shea) butter are contained in the composition it is preferred if the total quantity of cupuacu butter, murumuru butter and/or butyrospermum parkii (shea) butter is in the range from 0.5 to 20% by weight, more preferably 5% to 18% by weight and most preferred 8% to 15% by weight, calculated to the total weight of the composition.
- butyrospermum parkii (shea) butter is contained in the composition it is preferred if the total quantity of butyrospermum parkii (shea) butter is in the range from 0.5 to 20% by weight, more preferably 5% to 18% by weight and most preferred 8% to 15% by weight, calculated to the total weight of the composition.
- the composition comprises further an oil and/or wax component that is liquid under normal conditions it is preferred if at least one natural oil is contained.
- Preferred natural oils are selected from the list soya oil, cotton seed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, vegetable oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, avocado oil, peach kernel oil and/or the liquid fractions of coconut oil. Most preferred is vegetable oil.
- the composition comprises further oil and/or wax components that are liquid under normal conditions, it is preferred if the total quantity of those ingredients is in the range from 0.1% to 20% by weight, more preferably 0.5 to 4% by weight and most preferably 1.0 to 3.0% by weight, calculated to the total weight of the composition.
- the total quantity of natural oils if present, is in the range from 0.1% to 20% by weight, more preferably 0.5 to 4% by weight and most preferably 1.0 to 3.0% by weight, calculated to the total weight of the composition.
- the total quantity of natural oils selected from the list of soya oil, cotton seed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, vegetable oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, avocado oil, peach kernel oil and/or the liquid fractions of coconut oil, if present, is in the range from 0.1% to 20% by weight, more preferably 0.5 to 4% by weight and most preferably 1.0 to 3.0% by weight, calculated to the total weight of the composition.
- the total quantity of vegetable oil is in the range from 0.1% to 5% by weight, more preferably 0.5 to 4% by weight and most preferably 1.0 to 3.0% by weight, calculated to the total weight of the composition.
- Preferred embodiments of the invention are characterized in that at least one further oil or wax component is contained, which has a natural origin index of at least 0.5, whereby the natural origin index of the components is determined as outlined in the ISO 16128-2:2017; First Edition 2017-09. For example C18-38 Alkyl Beeswax has a Natural origin index of 0.55.
- the composition comprises further at least one fatty alcohol selected from the group of cetyl alcohol, stearyl alcohol and/or cetearyl alcohol.
- the total quantity of those fatty alcohols is in the range from 0.5 to 6% by weight, more preferably 1.5 to 5.5% by weight and most preferably from 2.2 to 4.2% by weight calculated to the total weight of the composition.
- preferred compositions according to the invention are characterized in that the composition comprises an outer aqueous phase and an inner oil phase.
- the composition comprises one or more polysaccharide, preferably at least one gum.
- Preferred polysaccharides are selected from the group of xanthan gum, succinoglycan, sclerotium gum and hydroxypropyl starch phosphate. Most preferred is xanthan gum.
- the total quantity of the polysaccharides is in the range from 0.01 to 1.0% by weight, more preferably 0.04 to 0.8% by weight, calculated to the total weight of the composition.
- the total quantity of the gums is in the range from 0.01 to 1.0% by weight, more preferably 0.04 to 0.8% by weight, calculated to the total weight of the composition.
- xanthan gum is contained in the composition, it is preferred if the total quantity of xanthan gum is in the range from 0.05 to 0.5% by weight, more preferably 0.1 to 0.4% by weight, calculated to the total weight of the composition.
- the composition does not comprise a polymer formed by homo- or copolymerization with acrylic acid and/or methacrylic acid.
- the quantities of those polymers is 0% by weight of the composition.
- the composition comprises ethanol in small quantities, ranging from 0.1 to 2% by weight, based on the total weight of the composition.
- compositions according to the invention are preferably further characterized in that they contain at least one fatty acid having 12 to 20 carbon atoms. If those fatty acids are contained, it is preferred if the total quantity of those is in the range from 0.1 to 2% by weight, calculated to the total weight of the composition. Further it is preferred if the composition comprises glycerol, whereby it is preferred if the total quantity of glycerol is in the range from 1.0 to 15% by weight, more preferably 1.5 to 10.0% and most preferably 3.0 to 8.0% by weight, calculated to the total weight of the composition.
- composition comprises p-anisic acid, levulinic acid and/or sodium levulinate.
- the total quantity of p-anisic acid, levulinic acid and/or sodium levulinate is in the range from 0.05 to 1% by weight, more preferably 0.1 to 0.8% by weight and most preferably 0.15 to 0.4% by weight, calculated to the total weight of the composition.
- composition comprises phenoxyethanol, ethylhexylglycerin and/or hydroxyacetophenone.
- phenoxyethanol is contained it is preferred if the total quantity of phenoxyethanol is in the range from 0.1 to 1% by weight, calculated to the total weight of the composition.
- ethylhexylglycerin is contained it is preferred if the total quantity of ethylhexylglycerin is in the range from 0.1 to 1% by weight, calculated to the total weight of the composition.
- hydroxyacetophenone is contained it is preferred if the total quantity of hydroxyacetophenone is in the range from 0.1 to 0.5% by weight, calculated to the total weight of the composition.
- the composition is characterized in that at least one UV- filter is contained.
- UV filter is understood as a substance which is listed in the IIV-A and IIV-B filter list in the Annex VI of the Regulation (EC) No 1223/2009 of the European Parliament and of the Council.
- composition comprises at least one organic UV-filter, which is selected from the group consisting of camphor benzalkonium methosulfate, homosalate, benzophenone-3, butyl methoxydibenzoylmethane, benzylidene camphor sulfonic acid, octocrylene, polyacrylamidomethyl benzylidene camphor, ethylhexyl methoxycinnamate, peg-25 paba, isoamyl p-methoxycinnamate, ethylhexyl triazone, drometrizole trisiloxane, diethylhexyl butamido triazone, 4-methylbenzylidene camphor, ethylhexyl salicylate, ethylhexyl dimethyl paba, methylene bis-benzotriazolyl tetramethylbutylphenol, methylene bis-benzotriazolyl
- the composition comprises bis-ethylhexyloxyphenol methoxyphenyl triazine, whereby the total quantity of bis-ethylhexyloxyphenol methoxyphenyl triazine is preferably in the range from 0.5 to 12% by weight, preferably 0.6 to 6% by weight, particularly preferably 0.7 to 3.5% by weight based on the total weight of composition.
- the composition comprises ethylhexyl salicylate, whereby the total quantity of ethylhexyl salicylate is preferably in the range from 0.5 to 12% by weight, preferably 2 to 9% by weight, particularly preferably 3 to 7.5% by weight based on the total weight of composition.
- the composition comprises ethylhexyl triazone, whereby the total quantity of ethylhexyl triazone is preferably in the range from 0.1 to 5% by weight, preferably 0.2 to 3% by weight, particularly preferably 0.3 to 1.5% by weight based on the total weight of composition.
- the composition comprises butyl methoxydibenzoylmethane, whereby the total quantity of butyl methoxydibenzoylmethane is preferably in the range from 0.5 to 12% by weight, preferably 0.6 to 6% by weight, particularly preferably 0.7 to 2.5% by weight based on the total weight of composition.
- the total quantity of all organic UV filters is in the range from 5 to 18% by weight, more preferably 7 to 15% by weight and most preferably 8.5 to 12.5% by weight, calculated to the total weight of the composition.
- the composition of the invention is free from octocrylene. That means the content of octocrylene is preferably 0% by weight based on the total weight of the composition. Further, it is preferred if the composition comprises titanium dioxide and/or zinc oxide in order to improve the light protection factor.
- the total content of water is in the range from 65% to 90% by weight, more preferably from 68 to 75% by weight, calculated to the total weight of the composition
- compositions were actually stable for a prolonged amount of time, even though no further emulsifier needed to be present. Accordingly it is further preferred if the composition comprises further emulsifier in a total quantity of less than 1.0% by weight, more preferably less than 0.5% by weight, more preferably less than 0.3% by weight, still more preferably less than 0.1% by weight and most preferably 0% by weight. Accordingly it is most preferred if the composition does not comprise further emulsifier.
- Emulsifiers are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "emulsifying agent”.
- Surfactants are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "surfactant”.
- compositions of the invention may further comprise active ingredients which can have a beneficial aspect for the human skin.
- active ingredients are glycyrrhetinic acid, arctiin, folic acid, coenzyme Q10 (ubiquinone), alpha-glucosylrutin, carnitine, carnosine, caffeine, natural and I or synthetic isoflavonoids, glycerylglucose, creatine, creatinine, taurine, tocopherol, tocopherol acetate, vitamin C, vitamin C phosphate, vitamin C palmitate, niacinamides, vitamin A palmitate, retinol, panthenol, glycyrrhiza inflata root extract, licochalcon A, 4-butylresorcinol, N - [(2,4-dihydroxyphenyl) thiazol-2-yl] isobutyramide, honociol and magnolol (also as a component of Magnolia- Extracts
- the pH of the composition is in the range from 3.5 to 7.5.
- viscosity values are disclosed in this document, all values relate unless otherwise described to a measurement at 25 ° C in a 150 ml wide neck bottle (VWR no .: 807-001) using Rheomat R 123 from proRheo.
- the Rheomat R 123 from proRheo GmbH is a rotation viscometer. The force is measured that is required to make the measuring body rotate in the sample at a specified speed. The viscosity is calculated from this torque, the speed of the measuring body and the geometric dimensions of the measuring system used.
- the measuring body used is measuring body No. 1 (item no. 200 0191), suitable for a viscosity range up to 10,000 [mPa s], speed range 62.5 min' 1 .
- Globulins legumin, vicilin and convicilin
- Minor parts of Albumin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne une composition cosmétique.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2021/050998 WO2022156876A1 (fr) | 2021-01-19 | 2021-01-19 | Formulations de protéines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2021/050998 WO2022156876A1 (fr) | 2021-01-19 | 2021-01-19 | Formulations de protéines |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022156876A1 true WO2022156876A1 (fr) | 2022-07-28 |
Family
ID=74418396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/050998 WO2022156876A1 (fr) | 2021-01-19 | 2021-01-19 | Formulations de protéines |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022156876A1 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103123A1 (fr) | 2005-03-29 | 2006-10-05 | Beiersdorf Ag | Preparation cosmetique donnant une sensation de legerete lorsqu'elle est appliquee sur la peau |
WO2008070368A2 (fr) * | 2006-11-01 | 2008-06-12 | Living Proof, Inc. | Procédés et compositions pour le soin de la peau |
US20100093599A1 (en) * | 2008-10-10 | 2010-04-15 | Jeffrey Wu | Shine control cleanser |
WO2012120290A2 (fr) * | 2011-03-04 | 2012-09-13 | Sana Pharma As | Formulations cosmétiques |
CN104523553A (zh) * | 2015-01-22 | 2015-04-22 | *** | 一种具有表皮保湿和皮肤抗皱作用的护肤化妆品及其制备和应用 |
WO2019204793A1 (fr) * | 2018-04-19 | 2019-10-24 | Phytoption Llc | Émulsifiants et leurs utilisations |
-
2021
- 2021-01-19 WO PCT/EP2021/050998 patent/WO2022156876A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103123A1 (fr) | 2005-03-29 | 2006-10-05 | Beiersdorf Ag | Preparation cosmetique donnant une sensation de legerete lorsqu'elle est appliquee sur la peau |
WO2008070368A2 (fr) * | 2006-11-01 | 2008-06-12 | Living Proof, Inc. | Procédés et compositions pour le soin de la peau |
US20100093599A1 (en) * | 2008-10-10 | 2010-04-15 | Jeffrey Wu | Shine control cleanser |
WO2012120290A2 (fr) * | 2011-03-04 | 2012-09-13 | Sana Pharma As | Formulations cosmétiques |
CN104523553A (zh) * | 2015-01-22 | 2015-04-22 | *** | 一种具有表皮保湿和皮肤抗皱作用的护肤化妆品及其制备和应用 |
WO2019204793A1 (fr) * | 2018-04-19 | 2019-10-24 | Phytoption Llc | Émulsifiants et leurs utilisations |
Non-Patent Citations (1)
Title |
---|
"International Cosmetic Ingredient Dictionary and Handbook", 2010 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2235456T3 (es) | Preparacion cosmetica de sustancias activas con un factor de proteccion contra los radicales sinergicamente mejorado. | |
US9119785B2 (en) | Cosmetic basic composition and its use | |
US20040109880A1 (en) | Cosmetic and/or pharmaceutical preparations | |
US20070224138A1 (en) | Cosmetic composition comprising gingko biloba and sunscreen agents | |
CN101765432A (zh) | Age的去糖化 | |
EP1815843A2 (fr) | Combinaisons synergétiques d'hydrolysats de protéines destinées au traitement des peaux mûres | |
DE102006062438A1 (de) | Kosmetische Zusammensetzungen zur Glättung und Straffung der Haut | |
EP2005941A2 (fr) | Compositions rajeunissant les cellules | |
CN101427989A (zh) | 化妆品用生物活性组合物 | |
DE102011084904A1 (de) | Hautstraffende kosmetische Zusammensetzungen mit verbessertem Hautgefühl | |
DE102008059703A1 (de) | Neue kosmetische Zusammensetzungen mit haarwuchsinhibierender Wirkung | |
WO2010049457A2 (fr) | Combinaison de principes actifs pour le traitement des peaux matures | |
KR20010109519A (ko) | 화장용 모발 보호제 | |
US20210338559A1 (en) | Acrylate-free cosmetic emulsion | |
JP2008001617A (ja) | リポ酸含有化粧料及び皮膚外用剤 | |
AU2016322914A1 (en) | Skin care compositions | |
DE102008032179A1 (de) | Rinse-off-Produkte mit Benefit-Wirkung auf die Haut | |
WO2022156876A1 (fr) | Formulations de protéines | |
JP2008074757A (ja) | 老化防止用皮膚外用剤 | |
DE102005026357A1 (de) | Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer oder lichtgeschädigter Haut | |
KR101728062B1 (ko) | 마유세라마이드를 함유한 화장료 조성물 | |
EP3773444B1 (fr) | Composition cosmetique pour une evaporation rapide de la sueur | |
US20020076423A1 (en) | Cosmetic or dermatological formulations for the care and cooling of the skin after sunbathing | |
DE102008025089A1 (de) | Zellverjüngende Zusammensetzungen | |
WO2022156877A1 (fr) | Formulation de protéines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21702377 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21702377 Country of ref document: EP Kind code of ref document: A1 |